An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
- 30 April 1994
- journal article
- review article
- Published by Elsevier BV in Virus Research
- Vol. 32 (1), 13-36
- https://doi.org/10.1016/0168-1702(94)90059-0
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Lack of detectable enhanced pulmonary histopathology in cotton rats immunized with purified F glycoprotein of respiratory syncytial virus (RSV) when challenged at 3–6 months after immunizationVaccine, 1993
- The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3)Virus Research, 1993
- Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeysVirus Research, 1992
- Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protectionArchiv für die gesamte Virusforschung, 1991
- Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virusVaccine, 1990
- Attenuation of Bovine Parainfluenza Virus Type 3 in Nonhuman Primates and Its Ability to Confer Immunity to Human Parainfluenza Virus Type 3 ChallengeThe Journal of Infectious Diseases, 1988
- Protection of weanling hamsters from experimental infection with wild‐type parainfluenza virus type 3 (para 3) by cold‐adapted mutants of para 3Journal of Medical Virology, 1986
- Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton ratVirus Research, 1985
- Evaluation of cold‐adapted adn temperature‐sensitive mutants of parainfluenza virus type 3 in weanling hamstersJournal of Medical Virology, 1984
- Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markersJournal of Medical Virology, 1982